Rigel Pharmaceuticals Inc Cash Flow Quality Index
Rigel Pharmaceuticals Inc cash flow quality index. Rigel Pharmaceuticals Inc (RIGL) has a Cash Flow Quality Index of 1.77x as of June 2026. Operating cash flow of $30.65 Million exceeds net income of $17.29 Million, indicating high earnings quality where cash backs reported profits. See Rigel Pharmaceuticals Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Rigel Pharmaceuticals Inc (2010–2025)
Cash flow quality index of Rigel Pharmaceuticals Inc from 2010 to 2025. Historical Cash Flow Quality Index for Rigel Pharmaceuticals Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Rigel Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Rigel Pharmaceuticals Inc Cash Flow Quality Index by Year (2010–2025)
Rigel Pharmaceuticals Inc cash flow quality index by year from 2010 to 2025. Year-by-year earnings quality comparison for Rigel Pharmaceuticals Inc. For the full cash flow conversion analysis, see Rigel Pharmaceuticals Inc cash conversion from operations.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | $75.66 Million | $367.02 Million | ▼ -88.5% |
| 2024 | 1.80x | $31.47 Million | $17.48 Million | ▲ +45.9% |
| 2010 | 1.23x | $46.74 Million | $37.89 Million | — |